# mRNA vaccines: Overview

Source page: https://www.materialinsights.org/technologies/mrna_vaccines/tech-overview/

#### What it does

The job the technology does for people, in a short paragraph

An mRNA vaccine trains the immune system by giving cells the instructions to make one harmless protein of a germ, instead of the germ itself. The first two were approved against COVID-19 in December 2020 ^[1]. More than 13 billion COVID-19 vaccine doses of all types, mRNA and others, had been given by 2023 ^[1].

as of 2026-11-11

#### How it works

The working principle in plain words, step by step

Cells use messenger RNA, a short-lived copy of a gene, as a template for making proteins ^[1]. An mRNA vaccine contains an mRNA that codes for one protein from the surface of a virus. The mRNA is made in a tank by enzymes copying a DNA template, without growing any cells ^[2]. Its building blocks are slightly changed so the body does not treat it as an invader and set off inflammation ^[1]. The mRNA is wrapped in tiny fat droplets, lipid nanoparticles, which protect it and carry it into cells ^[3]. After the injection, cells read the message, make the protein and show it to the immune system, which makes antibodies and memory cells. The mRNA itself is short-lived and soon breaks down.

as of 2026-11-11

#### Key figures

The handful of numbers that size it up, each with its unit, year and source

| Figure | Value | Unit | Year | Source |
|---|---|---|---|---|
| COVID-19 vaccine doses given worldwide, all types (not only mRNA), more than | 13 | billion doses | 2023 | ^[1] |
| Pfizer's reported revenue from Comirnaty, its mRNA vaccine (direct sales and alliance revenues) | 37,806 | million USD | 2022 | ^[5] |
| Pfizer's reported total revenue | 100,330 | million USD | 2022 | ^[5] |
| Years from the key finding on modified mRNA to approval | 15 | years | 2020 | ^[1] |

as of 2026-11-11. The dose count covers all COVID-19 vaccines, not only mRNA ones; it comes from the Nobel announcement of October 2023, so 2023 is the publication year, not a data year [1]. The revenue figures are Pfizer's own; about 38% of its 2022 revenue came from the vaccine (calculated: 37,806 / 100,330).

#### Where it is used

The main places and products the technology is found in

- COVID-19 vaccines, approved from December 2020 ^[1]
- National immunisation programmes and mass vaccination centres
- Clinics and pharmacies giving booster doses
- Research on vaccines against other infections and on cancer treatments ^[2]

as of 2026-11-11

#### Scale today

How much of it there is now: units in use, made each year and who uses it

**Made per year**
: No count of mRNA doses alone was found; more than 13 billion COVID-19 doses of all types had been given by 2023 ^[1]

**Unit**
: doses

**Year**
: 2023

**Note**
: The count is for all COVID-19 vaccines, so it is an upper bound for mRNA vaccines; 2023 is the year of the Nobel announcement that gives it.

as of 2026-11-11

#### Sources

1. [Press release: The Nobel Prize in Physiology or Medicine 2023](https://www.nobelprize.org/prizes/medicine/2023/press-release/) The Nobel Assembly at Karolinska Institutet, 2023
2. [mRNA vaccines - a new era in vaccinology](https://www.nature.com/articles/nrd.2017.243) Nature Reviews Drug Discovery (N. Pardi, M. J. Hogan, F. W. Porter and D. Weissman), 2018
3. [The tangled history of mRNA vaccines](https://media.nature.com/original/magazine-assets/d41586-021-02483-w/d41586-021-02483-w.pdf) Nature 597, 318 to 324 (Elie Dolgin), 2021
4. [Financial Performance (Pfizer 2022 Annual Review)](https://www.pfizer.com/sites/default/files/investors/financial_reports/annual_reports/2022/performance/) Pfizer

## Other sections

- [Summary](https://www.materialinsights.org/technologies/mrna_vaccines/index.md)
- [Science](https://www.materialinsights.org/technologies/mrna_vaccines/tech-science/index.md)
- [Evolution](https://www.materialinsights.org/technologies/mrna_vaccines/tech-evolution/index.md)
- [Materials](https://www.materialinsights.org/technologies/mrna_vaccines/tech-materials/index.md)
- [Energy footprint](https://www.materialinsights.org/technologies/mrna_vaccines/tech-energy-footprint/index.md)
- [Industries](https://www.materialinsights.org/technologies/mrna_vaccines/tech-industries/index.md)
